250 related articles for article (PubMed ID: 15105121)
1. Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis.
Barequet IS; Ben Simon GJ; Safrin M; Ohman DE; Kessler E
Antimicrob Agents Chemother; 2004 May; 48(5):1681-7. PubMed ID: 15105121
[TBL] [Abstract][Full Text] [Related]
2. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
3. Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis.
Barequet IS; Bourla N; Pessach YN; Safrin M; Yankovich D; Ohman DE; Rosner M; Kessler E
Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):223-9. PubMed ID: 21947265
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
5. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
Dajcs JJ; Thibodeaux BA; Girgis DO; Shaffer MD; Delvisco SM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3712-6. PubMed ID: 12454041
[TBL] [Abstract][Full Text] [Related]
6. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
Climo MW; Patron RL; Goldstein BP; Archer GL
Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
[TBL] [Abstract][Full Text] [Related]
8. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
[TBL] [Abstract][Full Text] [Related]
9. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
Dajcs JJ; Thibodeaux BA; Hume EB; Zheng X; Sloop GD; O'Callaghan RJ
Curr Eye Res; 2001 Jun; 22(6):451-7. PubMed ID: 11584345
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
[TBL] [Abstract][Full Text] [Related]
11. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
12. The In Vitro Evaluation of Tigecycline and the In Vivo Evaluation of RPX-978 (0.5% Tigecycline) as an Ocular Antibiotic.
Romanowski EG; Kowalski TA; O'Connor KE; Yates KA; Mah FS; Shanks RM; Kowalski RP
J Ocul Pharmacol Ther; 2016 Mar; 32(2):119-26. PubMed ID: 26545167
[TBL] [Abstract][Full Text] [Related]
13. Intrastromal Administration of Vancomycin to Maximize Its Early Effect on Methicillin-resistant Staphylococcus Aureus Keratitis: A Rabbit Study.
Ucgul AY; Ucgul RK; Behcet M
Ocul Immunol Inflamm; 2022 Aug; 30(6):1430-1435. PubMed ID: 33974478
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model.
Barequet IS; Habot-Wilner Z; Mann O; Safrin M; Ohman DE; Kessler E; Rosner M
Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):913-7. PubMed ID: 19280208
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Fukaya Y; Kurita A; Tsuruga H; Naito A; Nakaya S; Sato M; Kamata Y; Hirata H; Kambara Y; Kurasawa N; Wada T; Toyoda Y; Shirasawa E; Ohashi Y
J Ocul Pharmacol Ther; 2006 Aug; 22(4):258-66. PubMed ID: 16910867
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of teicoplanin and vancomycin on experimental methicillin-resistant staphylococcus aureus keratitis.
Ucgul AY; Behcet M
Int Ophthalmol; 2021 Apr; 41(4):1395-1402. PubMed ID: 33506369
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
Chang VS; Dhaliwal DK; Raju L; Kowalski RP
Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Mengeloğlu FZ; Küçükbayrak A; Bucak YY; Erdurmuş M; Taş T; Özyalvaçlı G; Bayram R; Bucak Ö; Akdeniz H
J Ocul Pharmacol Ther; 2013 Dec; 29(10):893-9. PubMed ID: 24070366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
